Radiotherapy in Combination With Sintilimab,GM-CSF and Fruquintinib in Patients With MSS mCRC
Ontology highlight
ABSTRACT: To evaluate the clinical efficacy and safety of hypofractionation radiotherapy combined with sintilimab,GM-CSF and Fruquintinib in Patients With MSS Metastatic Colorectal Carcinoma (mCRC)
DISEASE(S): Colorectal Neoplasms
PROVIDER: 2710363 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA